Literature DB >> 9536019

Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation.

K Gronert1, S P Colgan, C N Serhan.   

Abstract

Neutrophil (PMN) activation and recruitment are coordinated by ligand-operated surface receptors. These responses are involved in the tissue injury that follows hypoxia/reoxygenation. Here, we report that inflammatory mediators each evoke distinct and characteristic extracellular acidification rates (EAR) in both PMN and endothelial cells (EC) as measured by a Cytosensor microphysiometer. Leukotriene B4 (LTB4) and the peptide N-formylmethionyl-leucyl-phenylalanine were the most potent activators of EAR, whereas other potent stimuli including interleukin-8 and platelet-activating factor only weakly stimulated EAR in PMN. In contrast, other lipid-derived PMN mediators such as prostaglandin E2 and lipoxin A4 (LXA4) did not evoke EAR. Ligand-operated EAR exhibited desensitization as well as ligand specificity and sensitivity to pertussis toxin. Human endothelial cell agonists including histamine, prostacyclin stable analog and LXA4 each gave sharply different EAR responses, with only histamine evoking an EAR in these cells. Hypoxia/reoxygenation did not alter ligand-operated EAR from PMN, and similarly LTB4-stimulated PMN transendothelial migration, a functional response, was not influenced by either PMN or EC exposure to intervals of hypoxia/reoxygenation. LXA4 stable analogs inhibited PMN transendothelial migration (1 nM-1 microM), and this PMN-EC responsiveness to inhibition by a lipoxin stable analog (e.g., 16-phenoxy-LXA4) was enhanced approximately 2 log orders of magnitude after hypoxia/reoxygenation. Results demonstrate that ligand-receptor interactions evoke characteristic profiles of EAR and that some well-characterized ligand-receptor pairs (including interleukin-8, platelet-activating factor, prostaglandin E2 or LXA4) on these cell types either weakly activate the EAR pathway or are silent. Furthermore, hypoxia/reoxygenation did not alter LTB4 PMN responses but did heighten responsiveness to 16-phenoxy-LXA4, which suggests a potential protective role in leukocyte-mediated injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536019

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.

Authors:  N Chiang; K Gronert; C B Clish; J A O'Brien; M W Freeman; C N Serhan
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  In vivo visualization of skin inflammation by optical coherence tomography and two-photon microscopy.

Authors:  Bumju Kim; Seung Hun Lee; Calvin J Yoon; Yong Song Gho; G-One Ahn; Ki Hean Kim
Journal:  Biomed Opt Express       Date:  2015-06-15       Impact factor: 3.732

Review 3.  Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses.

Authors:  Ruth X Wang; Sean P Colgan
Journal:  Mol Aspects Med       Date:  2017-02-21

Review 4.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Authors:  Charles N Serhan; Nan Chiang; Thomas E Van Dyke
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

5.  Platelet-activating factor increases pH(i) in bovine neutrophils through the PI3K-ERK1/2 pathway.

Authors:  María A Hidalgo; Flavio Ojeda; Peter Eyre; Timothy P LaBranche; Carlos Smith; Juan L Hancke; Rafael A Burgos
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

6.  Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.

Authors:  N Chiang; I M Fierro; K Gronert; C N Serhan
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

7.  Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.

Authors:  M Hachicha; M Pouliot; N A Petasis; C N Serhan
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

8.  Multiplex profiling of inflammation-related bioactive lipid mediators in Toxocara canis- and Toxocara cati-induced neurotoxocarosis.

Authors:  Patrick Waindok; Elisabeth Janecek-Erfurth; Dimitri Lindenwald; Esther Wilk; Klaus Schughart; Robert Geffers; Laurence Balas; Thierry Durand; Katharina Maria Rund; Nils Helge Schebb; Christina Strube
Journal:  PLoS Negl Trop Dis       Date:  2019-09-26

9.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.

Authors:  Makoto Arita; Francesca Bianchini; Julio Aliberti; Alan Sher; Nan Chiang; Song Hong; Rong Yang; Nicos A Petasis; Charles N Serhan
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

10.  12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2.

Authors:  Toshiaki Okuno; Yoshiko Iizuka; Hiroshi Okazaki; Takehiko Yokomizo; Ryo Taguchi; Takao Shimizu
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.